Charles River Laboratories Announces Second-Quarter 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Charles River Laboratories (CRL) Tops Q2 EPS by 8c
July 31, 2019 7:14 AM EDTCharles River Laboratories (NYSE: CRL) reported Q2 EPS of $1.63, $0.08 better than the analyst estimate of $1.55. Revenue for the quarter came in at $657.6 million versus the consensus estimate of $662.51 million.
GUIDANCE:
Charles River Laboratories sees FY2019 EPS of $6.45-$6.60, versus the... More
